Bidan Huang

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

Jean‐Frédéric Colombel, Remo Panaccione, Peter Bossuyt et al. · The Lancet · 2017 · 912 citations

Medicine, Internal Medicine, Gastroenterology +3

Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials

Silvio Danese, Séverine Vermeire, Wen Zhou et al. · The Lancet · 2022 · 597 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +10

Effect of Levosimendan on the Short-Term Clinical Course of Patients With Acutely Decompensated Heart Failure

Milton Packer, Wilson S. Colucci, Lloyd D. Fisher et al. · JACC Heart Failure · 2013 · 434 citations

Medicine, Cardiology, Internal Medicine +9

Cardiovascular Safety of Testosterone-Replacement Therapy

A. Michael Lincoff, Shalender Bhasin, Panagiotis Flevaris et al. · New England Journal of Medicine · 2023 · 424 citations

Medicine, Endocrinology, Pharmacotherapy +17

Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials

Geert D’Haens, Remo Panaccione, Filip Baert et al. · The Lancet · 2022 · 387 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +9